…professional and community education initiatives. + Read more Diseases we research Male infertility Clinical Andrology Group areas of focus Genetic causes of male infertility: new knowledge leading to specific treatment…… Read more
…immune pathways contribute to conditions such as inflammatory bowel disease, asthma, metabolic diseases, and even neurodegeneration. Innate immune pathways investigated by Professor Masters include The inflammasome, a protein complex which…… Read more
…MJ, Flavell RA, Gerlic M, Kile BT, Papenfuss AT, Putoczki TL, Radford-Smith GL, Masters SL. (2018) NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease. Nat Commun. Sep 13;9(1):3728….… Read more
…mum and baby 3 November 2022 Creatine during pregnancy – a scientist’s story 14 September 2022 Creatine and pregnancy: what you need to know See more news articles about Bioenergetics…… Read more
After two years of unusually low influenza infections due to social distancing, flu season 2022 is shaping up as a bad one for Australia. Associate Professor Michelle Tate Influenza expert,…… Read more
…for patients living with PA. Using principles of implementation science and health economics, CONSEP is being implemented in general practices in Victoria, Tasmania and South Australia. Read more Endocrine hypertension…… Read more
…experimental and clinical studies directed towards understanding, and inhibiting, the mechanisms that contribute to perinatal brain injury and functional deficits associated with cerebral palsy. We strive towards the implementation of…… Read more
Overview The human placenta is a rich source of stem cells and stem-like cells. Our work is focused on a stem cell-like population of cells obtained from the human amnion,…… Read more
…unique combination of skills in microbiology and computational biology which she applies to understand the use of dietary components in re-structuring the gastrointestinal microbiome. By combining key microbiome technology and…… Read more
Media 2022 December Noxopharm autoimmune treatment pipeline bolstered with $1.5 million grant to medical research partner Associate Professor Michael Gantier Proactive Investors BiomeBank has raised $10.7m to fast-track its treatments…… Read more
